TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis

Oncogenic mutations in histologically normal endometrium: the new normal?

(2019) Vivian Lac et al.   JOURNAL OF PATHOLOGY

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience

(2018) David Capper et al.   ACTA NEUROPATHOLOGICA

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

(2018) Daniel J. Brat et al.   ACTA NEUROPATHOLOGICA

Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis

(2018) Nancy E. Thomas et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Human glioblastoma arises from subventricular zone cells with low-level driver mutations

(2018) Joo Ho Lee et al.   NATURE

cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification

(2016) David N. Louis et al.   BRAIN PATHOLOGY

Characteristics of gliomas in patients with somatic IDH mosaicism

(2016) Charlotte Bonnet et al.   Acta Neuropathologica Communications

Chordoid Gliomas of the Third Ventricle Share TTF-1 Expression With Organum Vasculosum of the Lamina Terminalis

(2015) Franck Bielle et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas

(2015) Ekkehard Hewer et al.   HISTOPATHOLOGY

Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors

(2015) Annika Blank et al.   VIRCHOWS ARCHIV

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

(2014) David N. Louis et al.   BRAIN PATHOLOGY

Glioma-like proliferation in a cortical hamartoma of tuberous sclerosis complex

(2014) Ekkehard Hewer et al.   Brain Tumor Pathology

Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types

(2013) Inti Zlobec et al.   Journal of Translational Medicine

Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice

(2013) F. Burel-Vandenbos et al.   NEURO-ONCOLOGY

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gliosis Versus Glioma?

(2012) Marie Rivera-Zengotita et al.   ADVANCES IN ANATOMIC PATHOLOGY

Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance

(2011) W Glenn McCluggage et al.   HISTOPATHOLOGY

A Sensitive and Specific Diagnostic Panel to Distinguish Diffuse Astrocytoma From Astrocytosis: Chromosome 7 Gain With Mutant Isocitrate Dehydrogenase 1 and p53

(2011) Sandra Camelo-Piragua et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes

(2010) David Capper et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

WT1 Is Not a Reliable Marker to Distinguish Reactive from Neoplastic Astrocyte Populations in the Central Nervous System

(2010) T. David Bourne et al.   BRAIN PATHOLOGY

EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis

(2010) Fanny Burel-Vandenbos et al.   JOURNAL OF NEURO-ONCOLOGY

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

(2009) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis

(2009) Sandra Camelo-Piragua et al.   ACTA NEUROPATHOLOGICA

Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors

(2009) David Capper et al.   BRAIN PATHOLOGY

Diagnostic Use ofIDH1/2Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues

(2009) Craig Horbinski et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

WT1 Expression Distinguishes Astrocytic Tumor Cells from Normal and Reactive Astrocytes

(2008) Jens Schittenhelm et al.   BRAIN PATHOLOGY

J1-31 protein expression in astrocytes and astrocytomas

(2008) Shanop Shuangshoti et al.   NEUROPATHOLOGY